May 05, 2016 editorial The “cancer immunogram” Science DOI: 10.1126/science.aaf2834 OpenAlex Authors 0 Author list not loaded yet. Cited by 25 stored of 749 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Associations between spatial distribution of immune cell subsets and clinical outcomes in patients with advanced melanoma treated with immune checkpoint inhibitors: results from the PUMA challenge 2026 Medical Image Analysis article Medicine Cancer Immunotherapy and Biomarkers Open access 0 citations Early C-reactive protein kinetics predict outcomes in unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors: a multicenter, observational study comparing different C-reactive protein kinetic definitions 2026 Frontiers in Oncology article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access 0 citations Efficient generation of human cDC1-like cells to detect and enhance tumor-reactive T cells via CD4+ T cell help 2026 Cell Reports Methods article Immunology and Microbiology Immunotherapy and Immune Responses Open access 0 citations AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response 2026 European Journal of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access 2 citations Associations between spatial distribution of immune cell subsets and clinical outcomes in patients with advanced melanoma treated with immune checkpoint inhibitors: results from the PUMA challenge 2026 medRxiv preprint Medicine Cancer Immunotherapy and Biomarkers Open access 0 citations Lessons from neoadjuvant immunotherapy in melanoma: understanding antitumour immunity and tumour escape 2025 Nature reviews. Immunology review Medicine Cancer Immunotherapy and Biomarkers 18 citations Dissecting response to neoadjuvant immunotherapy-treated melanoma using cancer-immunity cycle-associated signatures 2025 Cancer Immunology Immunotherapy article Medicine Cancer Immunotherapy and Biomarkers Open access 3 citations Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study 2025 JNCI Journal of the National Cancer Institute article Medicine Cancer Immunotherapy and Biomarkers Open access 11 citations Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality 2025 npj Breast Cancer article Immunology and Microbiology Immune cells in cancer Open access 21 citations Multimodal analysis unveils tumor microenvironment heterogeneity linked to immune activity and evasion 2024 iScience article Medicine Cancer Immunotherapy and Biomarkers Open access 16 citations Integrated noninvasive diagnostics for prediction of survival in immunotherapy 2024 Immuno-Oncology Technology article Medicine Radiomics and Machine Learning in Medical Imaging Open access 3 citations Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma 2024 Journal for ImmunoTherapy of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access 25 citations Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors 2024 Nature Communications article Medicine Cancer Immunotherapy and Biomarkers Open access 27 citations Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study 2024 medRxiv preprint Medicine Cancer Immunotherapy and Biomarkers Open access 0 citations Nanomedicine Tumor Targeting 2024 Advanced Materials article Materials Science Nanoparticle-Based Drug Delivery Open access 289 citations Multimodal analysis unveils tumor microenvironment heterogeneity linked to immune activity and evasion 2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access 0 citations Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in Melanoma 2023 Cancer Discovery article Medicine Cancer Immunotherapy and Biomarkers 23 citations Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial 2023 Nature Medicine article Medicine Salivary Gland Tumors Diagnosis and Treatment Open access 65 citations Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma 2023 Journal of Clinical Investigation article Medicine Cancer Immunotherapy and Biomarkers Open access 31 citations Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors 2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access 0 citations 1–20 of 25 Page 1 / 2 Next → References 0